Metabolic reprogramming is fundamental to biological homeostasis, enabling cells to adjust metabolic routes after sensing altered availability of fuels and growth factors. ULK1 and ULK2 represent key integrators that relay metabolic stress signals to the autophagy machinery. Here, we demonstrate that, during deprivation of amino acid and growth factors, ULK1/ 2 directly phosphorylate key glycolytic enzymes including hexokinase (HK), phosphofructokinase 1 (PFK1), enolase 1 (ENO1), and the gluconeogenic enzyme fructose-1,6-bisphosphatase (FBP1). Phosphorylation of these enzymes leads to enhanced HK activity to sustain glucose uptake but reduced activity of FBP1 to block the gluconeogenic route and reduced activity of PFK1 and ENO1 to moderate drop of glucose-6-phosphate and to repartition more carbon flux to pentose phosphate pathway (PPP), maintaining cellular energy and redox homeostasis at cellular and organismal levels. These results identify ULK1/2 as a bifurcate-signaling node that sustains glucose metabolic fluxes besides initiation of autophagy in response to nutritional deprivation.
INTRODUCTION
Metazoan cells rely on balanced availability of nutrients including glucose and amino acids as well as growth factors to maintain cell growth and survival. By degrading internal cellular components, autophagy functions to replenish anabolic substrates and energy under nutrient-poor or other stress conditions as well as in diverse pathophysiological processes (Choi et al., 2013; Rabinowitz and White, 2010; Wang et al., 2010; Xie and Klionsky, 2007) . Genetic delineation of the critical components for autophagy has revealed numerous factors (Galluzzi et al., 2014; Mizushima et al., 2011; Nakatogawa et al., 2009 ), among which unc-51-like kinase 1 and 2 (ULK1/2) play an initiating role by coupling signals from nutrient-sensing proteins, including mechanistic target of rapamycin (mTOR) and AMP-activated protein kinase (AMPK) to the downstream autophagic factors, leading to the formation of autophagosomes (Egan et al., 2011; Kim et al., 2011; Jung et al., 2009 ). However, whether ULK1/2 may act as a multi-branching node connecting nutritional stress signals to other metabolic pathways, such as the pathways for glucose metabolism, remains unknown.
Glucose is the most-common source of energy for almost all living organisms, and exquisite mechanisms in the regulation of glucose metabolic fluxes have been evolved to enable cells to meet different intrinsic growth requirements or to adapt to variations of extracellular nutritional supply (Hammerman et al., 2004; Levine and Puzio-Kuter, 2010; Wellen and Thompson, 2012) . In mammalian cells, glucose catabolism starts with its conversion to glucose-6-phosphate (G6P), which is catalyzed by hexokinase (HK), a rate-limiting step of glycolysis (Wilson, 2003) . G6P is the branch point for proceeding to glycolysis or the pentose phosphate pathway (PPP) or to be stored as glycogen in certain type of cells. For glycolysis, G6P is first isomerized to fructose-6-phosphate (F6P) that is further converted into fructose-1,6-bisphosphate (F-1,6-P) by phosphofructokinase 1 (PFK1), the committed step of glycolysis (Mor et al., 2011) . Following the split of F-1,6-P into two trioses by aldolases, enolase 1 (ENO1) functions in the conversion of 2-phosphoglycerate (2PG) to phosphoenolpyruvate (PEP), the ninth and penultimate step of glycolysis (Díaz-Ramos et al., 2012) . FBP1 reverses the reaction catalyzed by PFK1 and plays a vital role in gluconeogenesis. Recent studies also revealed that inhibition of FBP1 enzymatic activity strongly increases glycolysis both in non-transformed and tumor cells (Dong et al., 2013; Li et al., 2014) .
The PPP shunt is considered as the major contributor of reducing equivalents in the form of reduced nicotinamide adenine dinucleotide phosphate (NADPH) for reductive biosynthesis and maintaining cellular redox homeostasis (Fan et al., 2014) . Inborn errors in PPP have been observed to be associated with various diseases such as fava-bean-induced hemolytic anemia, known as favism, which is caused by the deficiency of G6P dehydrogenase (G6PD), an X-linked recessive genetic condition that is particularly common in people of Mediterranean and African origin (Beutler, 2008) . G6PD is the rate-limiting enzyme that catalyzes the initial step of the PPP shunt, oxidizing G6P to phosphogluconolactone while nicotinamide adenine dinucleotide phosphate (NADP + ) is reduced to NADPH. Regulation of glycolytic enzymes to increase the PPP flux has been demonstrated as an important way for cells to adapt to various stresses (Bensaad et al., 2006; Yi et al., 2012; Anastasiou et al., 2011) .
Here, by combining in vitro reconstitution assays, generation of phospho-specific antibodies, and genetic manipulation, we identify HK, PFK1, FBP1, and ENO1 in the glucose metabolic pathways as direct phosphorylation substrates of ULK1/2. Phosphorylation of these enzymes occurs virtually only under nutritional stresses. Metabolomic analyses illustrate that, besides their classical role in the induction of autophagy to recycle cellular components to sustain energy supply and limit the generation of reactive oxygen species (ROS) during nutritional stresses, ULK1/2 function in the maintenance of intracellular energy and redox balance by allocating more G6P to the PPP to promote the generation of reducing potential for ROS detoxification while sustaining overall glucose catabolism. These findings establish an important adaptive mechanism for the reprogramming of glucose metabolic fluxes in response to nutrient deprivation, and understanding of this regulatory mechanism may offer us new strategies for prevention and treatment of human metabolic diseases.
RESULTS

Depletion of ULK1/2 Leads to Reduction of Glycolytic Flux during Amino Acid and Serum Starvation
To explore a possible link between ULK1/2 activation and regulation of glucose metabolism, we first knocked down ULK1 and ULK2 separately or together in the human colorectal cancer HCT116 cells ( Figure 1A ). Despite the presence of glucose, ULK1/2 can be activated upon deprivation of amino acid and/ or serum (Lin et al., 2012; Russell et al., 2013; Shang et al., 2011) . We found that, whereas knockdown of either ULK1 or ULK2 singly led to a moderate reduction in the rates of glucose consumption and lactate production in starvation medium lacking both amino acid and serum, ULK1 and ULK2 double knockdown (ULK1/2 DKD) resulted in a severe reduction of glycolytic flux ( Figure 1A ), indicating that both ULK1 and ULK2 are involved in the maintenance of glucose catabolism. Similarly, depletion of ULK1/2 in human osteosarcoma U2OS cells, human breast cancer MCF7 cells, or mouse embryonic fibroblasts (MEFs) also resulted in significant reduction of glucose utilization during the starvation (Figures 1B and S1A-S1E), demonstrating that ULK1/2 play a general role in regulating glucose metabolism in various cell types. Likewise, wild-type (WT) cells also displayed higher glucose consumption and lactate production than cells depleted of ULK1/2 after treatment of rapamycin that activates ULK1 by inhibiting mTORC1-mediated phosphorylation at Ser 758 ( Figure S1F ). Moreover, reconstitution of the ULK1/2 DKD cells with WT-ULK1, but not with its catalytically inactive (KI) form, restored the glycolytic flux during starvation ( Figures 1C and S1G) .
The kinase activities of ULK1/2 are highly dependent on their assembling into an $3-MDa complex with at least FIP200, ATG13, and ATG101 subunits, and depletion of any of these components would render ULK1/2 inactive (Hara et al., 2008; Hosokawa et al., 2009a Hosokawa et al., , 2009b . We therefore knocked down these genes in HCT116 cells separately (Figures S1H-S1J) and observed similar reduction of glycolytic flux to that caused by depletion of ULK1/2 ( Figures 1D and S1L ). To assess whether the attenuation of glucose catabolism was directly caused by the decrease of autophagic activity resulting from the disruption of ULK1/2 complex, several downstream genes essential for autophagy (Galluzzi et al., 2014; Mizushima et al., 2011; Rabinowitz and White, 2010; Xie and Klionsky, 2007) , including ATG5, ATG7, and BECN1, were separately knocked down ( Figure S1K ). Interestingly, no significant changes of glucose consumption and lactate production were detected in the knockdown cells compared to the control cells ( Figures 1D and S1L ). Similar results were also obtained using Atg5 À/À MEFs (Figures 1E and S1M), in which conventional autophagy is fully blocked (Kuma et al., 2004) . Together, these results indicate an important role of ULK1/2 in the regulation of glycolytic flux independent of the downstream autophagic events. We next assayed the activities of enzymes in the glycolytic pathway by using lysates from control and ULK1/2 DKD HCT116 cells placed either in complete medium or medium deprived of both amino acid and serum. Intriguingly, it was found that starvation led to increased catalytic activity of HK but reduced activity of PFK1. Reduced activities caused by starvation were also detected for FBP1 and ENO1. Meanwhile, the changes of the activities of the four enzymes after starvation did not occur in ULK1/2 DKD cells ( Figures 1F-1I ). We also performed similar experiments in WT and Ulk1/2 À/À MEFs and found again that, in the absence of Ulk1/2, these metabolic enzymes were much less sensitive to starvation (except that the activity of FBP1 in MEFs was too low to be detected; Figures S1N-S1Q). Of note, the activities of many other metabolic enzymes, such as phosphoglycerate kinase (PGK) or G6PD, did not show significant variation in either control or ULK1/2 DKD cells (Figures S1S and S1T). Importantly, total protein levels for all the metabolic enzymes tested were unchanged ( Figures 1J, S1R , and S1U). In addition, the enzymatic activities of HK, PFK1, and ENO1 changed similarly during starvation in Atg5 À/À MEFs to those in the WT MEFs (Figures S1V-S1Z), confirming that autophagic activity per se is not required for the regulation of glycolytic flux during amino acid and serum starvation.
ULK1 Directly Phosphorylates Glycolytic Enzymes and Affects Their Enzymatic Activities
We next asked whether HK, PFK1, FBP1, and ENO1 could be the direct substrates for the serine/threonine kinases ULK1/2. Coexpression of WT, but not the KI form of, ULK1 with representative forms of these four metabolic enzymes resulted in different electrophoretic mobility shifts in gels containing Phos-tag that retards the mobility of phosphorylated proteins ( Figure 2A ; Kinoshita et al., 2006) . Treatment of the immunoprecipitated enzymes with calf-intestinal alkaline phosphatase (CIP) effectively diminished the upper bands ( Figure 2A ). In vitro kinase assays using purified bacterially expressed metabolic enzymes and purified Histagged ULK1 expressed in insect cells further confirmed that ULK1 could directly phosphorylate these enzymes ( Figure 2B ). Similar results were also obtained using ULK2 as the kinase (data not shown).
The four phosphorylated enzymes were then subjected to mass spectrometry, and multiple phosphorylated serine residues for each enzyme were identified ( Figures S2A-S2D ). Mutants carrying alterations of these serine residues to alanine singly or in combination were then constructed. It was found that, for HK1, combined mutation of Ser 124 and Ser 364 to alanine strongly diminished the phosphorylation signal ( Figure 2C ); for PFK1 (M isoform), Ser 74 and Ser 762 were identified to be the critical residues ( Figure 2D) ( Figure 2F ). Sequence alignment indicates that most of these serine residues targeted by ULK1 are highly conserved across different species ( Figures S2A-S2D ). Importantly, the amino acid sequences flanking the phosphorylated residues generally conform to the consensus phosphorylation motif identified previously for the substrates of ULK1 (Egan et al., 2015) or ATG1 (yeast ortholog of ULK1/2; Papinski et al., 2014) . Polyclonal antibodies that specifically recognize Ser
762
-phosphorylated PFK1, Ser 63 -phosphorylated FBP1, or Ser
282
-phosphorylated ENO1 was then produced ( Figures 2D-2F ). Ser 124 -phosphorylated HK1 happens to be recognized by a commercially available antibody that targets a sequence context-dependent phosphoserine motif (referred here as P-S124-HK1 antibody; Figure 2C ). We found that the amount of either the exogenous or endogenous phosphorylated enzymes increases in medium deprived of amino acid and/or serum, whereas knockdown of ULK1/2 abolished their phosphorylation (Figures 2G and S2E) . Furthermore, reconstitution of ULK1/2 DKD cells with WT-ULK1, but not KI-ULK1, restored the phosphorylation of these enzymes ( Figure 2H ). Finally, treatment of rapamycin, which is known to active ULK1/2 as a result of inhibition of mTOR, in HCT116 cells also induced the phosphorylation of these enzymes ( Figure 2I ). These in vitro and in vivo results indicate that ULK1 is a bona fide kinase for HK, PFK1, FBP1, and ENO1. We next tested whether phosphorylation of these enzymes by ULK1 directly accounts for the changes of their enzymatic activities. Co-expression of ULK1 strongly increased the activity of WT-HK1, whereas the activities of WT forms of PFK1, FBP1, and ENO1 were heavily suppressed by ULK1 ( Figures 3A-3E) . Meanwhile, the activities of ULK1-nonphosphorylatable mutants (SA mutants or 2SA-) of these enzymes were not affected. The serine to aspartate mutants for each enzyme were also created (SD mutants or 2SD-), and it was found that 2SD-HK1 and 2SD-FBP1 can well mimic the phosphorylated states of these two enzymes whereas 2SD-PFK1 and 2SD-ENO1 own prosperities more like their respective SA mutants ( Figures 3A-3E ). We also determined the Michaelis constant (K m ) values of the enzymes and found that ULK1-mediated phosphorylation had little effect on the binding affinity of each enzyme to its substrate (Figure S3A ). The spatial locations of the serine residues targeted by ULK1 are shown in Figure S3B by structural remodeling.
Phosphorylation of HK and FBP1 by ULK1 Sustains Glycolytic Rate whereas ULK1-Mediated Phosphorylation of PFK1 and ENO1 Promotes PPP Flux To explore the functional consequences of ULK1-mediated phosphorylation of these enzymes of glucose metabolism during nutritional stresses, we first generated HCT116 cell lines in which the expression of HK (including HK1 and HK2), PFK1 (including M, L, and P isoforms), FBP1, or ENO1 was stably knocked down ( Figure S4A ). As expected, depletion of HK, PFK1, or ENO1 exhibited decreased glucose consumption and lactate production, whereas cells expressing short hairpin RNA (shRNA)-targeting FBP1 that functions in the gluconeogenic route showed increased glycolytic flux (Figures 4A and S4B ; Dong et al., 2013; Li et al., 2014 Figures 4G and S4E) . Importantly, the increased HK enzymatic activity and decreased activities of PFK1 and ENO1 during ULK1/2 activation may increase the ratio of glucose flux going through PPP to keep generating reducing forces to eliminate the elevated ROS during amino acid and serum deprivation (Scherz-Shouval et al., 2007) . Using [1, [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]glucose as a tracer, glycolytic intermediates including G6P/F6P, FBP, GAP/DHAP, 2PG/3PG, PEP, pyruvate and lactate, and PPP intermediates including R5P/X5P, E4P, and S7P were measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS) ( Figure S4F ). We found that HK-KD or FBP1-KD cells reconstituted with SA form of HK1 or FBP1 contained lower levels of labeled glycolytic and PPP intermediates than cells reconstituted with their corresponding WT forms cultured in starvation medium, but not in complete medium ( Figures 4H, 4I , S4G, and S4H). On the other hand, cells reconstituted with 2SA-PFK1 or 2SA-ENO1 contained lower levels of their corresponding upstream glycolytic intermediates (G6P/F6P for PFK1 and G6P/F6P, FBP, and GAP/DHAP for ENO1) and all the PPP intermediates but higher levels of their corresponding downstream intermediates (FBP, GAP/DHAP, 2PG/3PG, PEP, pyruvate, and lactate for PFK1 and 2PG/3PG, PEP, pyruvate, and lactate for ENO1) than cells reconstituted with their WT counterparts during starvation ( Figures 4J, 4K , S4I, and S4J). Meanwhile, we found that 30.6% ± 4.5% of HK1, 38.8% ± 5.2% of PFK1, 25.5% ± 4.0% of FBP1, and 32.1% ± 6.7% of ENO1 are phosphorylated by ULK1/2 after amino acid and growth factor starvation ( Figure 4L ). Furthermore, ULK1/2 DKD cells displayed severely decreased intracellular G6P, PEP, pyruvate, and lactate levels during the starvation compared to those in control cells ( Figures S4M  and S4N) .
With the isotope labeling as designed, lactate containing one 13 C atom (*) (M+1) is derived only from PPP flux ( Figure S4F) whereas lactate containing two 13 C atoms (**) (M+2) is mostly derived from direct glycolytic flux without going through PPP. We found that, during amino acid and serum starvation, PFK1-KD cells reconstituted with WT-PFK1 displayed higher PPP flux (based on the ratio of lactate* versus lactate**) comparing to PFK1-KD cells expressing 2SA-PFK1 ( Figure 4M ). Similar results were obtained in ENO1-KD cells reconstituted with WT-ENO1 and 2SA-ENO1. The differences of PPP flux were not found in those cells cultured in complete medium ( Figure S4K ). their corresponding WT forms at all times ( Figures 4M and S4K ).
The PPP results were confirmed by measuring the PPP-dependent 14 CO 2 production from [1-14 C]glucose ( Figure S4L ) and by NMR spectroscopy-based method ( Figures S4O and S4P) . Importantly, we detected a robust increase in the ratio of PPP flux versus direct glycolytic flux during amino acid and serum Error bars denote SEM. Statistical analysis was performed by ANOVA followed by Tukey in (A), (F), and (G) and by Student's t test in (H)-(N) (*p < 0.05; **p < 0.01). See also Figure S4 . starvation in WT, but not in Ulk1/2 À/À , MEFs ( Figures 4N and   S4Q ). Similarly, knocking down of ULK1/2 also decreased the PPP flux in U2OS and MCF7 cells during starvation ( Figure S4R ).
ULK1-Mediated Phosphorylation of Glucose Metabolic Enzymes Protect Cells from ROS-Associated Cell Death
Consistent with the crucial function of PPP in generation of reducing power, intracellular NADPH/NADP + and GSH levels decreased in PFK1-KD or ENO1-KD cells expressing SA or SD mutant of PFK1 or ENO1 during starvation comparing to their corresponding WT controls ( Figures 5A and 5B) . Moreover, much-higher ROS levels and higher percentages of cell death were detected in starved cells with knockdown of enzymes reconstituted with SA mutants of HK1, FBP1, PFK1, or ENO1 than cells expressing their WT counterparts ( Figures S5A and  5C ). In addition, cells expressing SD mutant of HK1 or FBP1 demonstrate lower ROS and the percentage of cell death than cells expressing the WT form whereas 2SD-PFK1 or 2SD-ENO1 owns prosperities more like their respective SA mutants ( Figures S5A and 5C ).
Next, we blocked the entry of G6P to PPP by knocking down G6PD, the rate-limiting enzyme for PPP ( Figure 5D ), and found that depletion of G6PD strongly increased the ROS level and accelerated cell death in starved HCT116 cells (Figures 5E and  5F ). Finally, addition of antioxidant N-acetylcysteine (NAC) or catalase (CAT) that catalyzes the conversion of hydrogen peroxide to water and oxygen effectively decreased the ROS level and alleviated cell death in ULK1/2 DKD or Ulk1/2 À/À cells in response to starvation ( Figures 5G, 5H , and S5B). The higher level of 3PG in cells expressing WT-ENO1 comparing to those expressing 2SA-ENO1 during starvation ( Figure 4K ) could possibly lead to more-active de novo serine synthesis to further support the production of NADPH (Figure S5C) . However, in the absence of amino acids, serine pathway, which requires input from glutamine for transamination reaction, is most likely blocked. Indeed, we found that depletion of PHGDH, the first enzyme directing 3PG to the serine pathway, did not affect ROS, NADPH/NADP + , or cell death level in HCT116 cells during amino acid and serum starvation ( Figures S5D-S5H ), indicating that serine pathway did not significantly contribute to the production of NADPH under such circumstance.
ULK1/2 Reprogram Glucose Metabolism Independently of Autophagy
To further ascertain an autophagy-independent role of ULK1/2 in the regulation of glucose metabolism, we analyzed the glucose metabolic fluxes in Atg5 À/À MEFs with or without knockdown of Ulk1/2. As previously reported (Kuma et al., 2004) , autophagy was deficient in Atg5 À/À MEFs as monitored with the degradation of p62 and lipidation of microtubule-associated protein 1 light chain 3 (LC3) during amino acid and serum starvation (Figure 6A) . We found that, in cells expressing shRNAs targeting Ulk1/2 in the Atg5 À/À background, significantly lower glucose consumption, lactate production, and PPP flux could still be Error bars denote SEM. Statistical analysis was performed by ANOVA followed by Tukey (*p < 0.05; **p < 0.01). See also Figure S5 .
observed under starvation condition ( Figure 6B ). Moreover, knockdown of Ulk1/2 in Atg5 À/À MEFs led to a further decrease of NADPH/NADP + as well as GSH and a further increase of ROS level and percentage of cell death compared to those in Atg5 À/À MEFs ( Figures 6C-6F ), and addition of CAT, the antioxidant, strongly alleviated cell death in response to starvation (Figure 6F) . These results suggest that, during nutritional stresses, autophagy contributes to the maintenance of cellular redox homeostasis whereas ULK1/2 function simultaneously to further accelerate ROS clearance and enhance cell survival by direct reprogramming of glucose metabolism.
ULK1/2 Maintain Glycolytic Flux, PPP, and Redox Homeostasis at Both Cellular and Organismal Levels
Lacking mitochondria, red blood cells (RBCs) extensively rely on glycolysis for energy production and PPP to generate reducing forces to eliminate ROS from both endogenous and exogenous sources (Beutler, 2008) . The ROS would otherwise damage RBCs and impair their ability in oxygen delivery, which contributes to the pathology of a number of diseases (Mohanty et al., 2014; Patra and Hay, 2014) . We found that, like FIP200 À/À mouse embryos (Gan et al., 2006) , most of Ulk1/2 À/À embryos are especially pale at embryonic day 15.5 (E15.5) compared to their WT littermates ( Figure S6A ). Interestingly, deficiency of Ulk1 alone, but not Ulk2, led to increased accumulation of p62 and the mitochondrial marker protein CoxIV ( Figure 7A ), confirming an important autophagic role of Ulk1 in erythrocyte maturation (Kundu et al., 2008) . However, much-reduced glycolytic flux and PPP activity as well as increased ROS level were detected in RBCs from Ulk1/2
embryos ( Figures 7B, 7C , S6B, and S6C), indicating a complementary but pivotal function of Ulk1 and Ulk2 in the regulation of glucose metabolism of RBCs during embryonic period in vivo.
In line with these findings, we found that Ulk1/2 À/À RBCs are more prone to lysis ( Figure S6D ) and displayed fractured membrane ( Figure S6E ). More intriguingly, unlike MEFs and other cells, Ulk1/2 À/À RBCs display altered glucose utilization even in complete medium ( Figure 7B ). The critical role of Ulk1 during maturing of RBCs suggests its activation in spite of abundant supply of nutrients around (Kundu et al., 2008) . Indeed, we found that, even under complete medium condition, mTORC1 activity in RBCs is maintained in an inactive state ( Figure 7D ), likely because RBCs lack lysosome, which is essential for mTORC1 activation (Laplante and Sabatini, 2012), allowing Ulk1/2 to be (F) Cell death rate of WT or Atg5 À/À MEFs expressing control shRNA or shRNAs targeting Ulk1/2 placed in complete medium or medium free of amino acid and serum with or without CAT (600 U/ml) for 18 hr. Statistical results of three independent experiments are shown on the right. Error bars denote SEM. Statistical analysis was performed by ANOVA followed by Tukey (*p < 0.05; **p < 0.01).
constantly activated. Next, we used NAC, the ROS scavenger, to test whether administration of this antioxidant could rescue the defects of Ulk1/2 À/À embryos. In consonance with the results obtained in HCT116 and MEFs showing that addition of NAC or the other antioxidant, CAT, effectively decreased the ROS level and mitigated cell death in ULK1/2 DKD or Ulk1/2 À/À cells during nutrient starvation ( Figures 5G, 5H , and S5B), we found that supply of NAC alleviated the paleness of Ulk1/2 À/À embryos ( Figure S6F ). Moreover, we found that the body weight of Ulk1/ 2 À/À mouse embryos (Cheong et al., 2014) was also restored to normal range in response to the supply of NAC ( Figure 7E ). These results demonstrate that the failure in the maintenance of a regular PPP flux, which further leads to the disrupted redox balance, is the major cause for the many defects of Ulk1/2 À/À embryos. During the breeding, half of the mice had access to normal water and the other half to water supplemented with 40 mM NAC. Only litters containing Ulk1/2 À/À embryos were included in the analysis.
(F) Model for ULK1/2-mediated regulation of glucose metabolic fluxes. Error bars denote SEM. Statistical analysis was performed by ANOVA followed by Tukey in (B) and (E) (*p < 0.05; **p < 0.01). See also Figure S6 .
DISCUSSION
In this study, we demonstrate a model that, under deprivation of amino acid and growth factors, the autophagy-initiation kinases ULK1/2 act as a key signaling node to sustain glycolysis and at the same time repartition more carbon flux to PPP through phosphorylating multiple enzymes in the glucose metabolic pathways, including HK, PFK1, FBP1, and ENO1 ( Figure 7F ). On one hand, phosphorylation of HK renders its enzymatic activity increased, promoting the conversion of glucose to G6P and subsequently glucose uptake, such that the glycolytic flux is sustained in control cells compared to cells depleted of ULK1/2 under the same nutritional stresses. It is also important to note that, because HK is product inhibited by G6P, the increase in the V max of HK by ULK1/ 2-mediated phosphorylation could probably compensate for the higher product inhibition of G6P in ULK1/2-containing cells during starvation. Meanwhile, the reduced activity of FBP1 after ULK1/2-dependent phosphorylation minimizes the reversal of F-1,6-P back to F6P, indirectly drawing more glucose toward catabolism.
On the other hand, ULK1/2-mediated phosphorylation of PFK1 and ENO1 inhibits their enzymatic activity and modulates glycolytic flux in an opposite way comparing to the effects of HK and FBP1 when assayed individually ( Figures 4F, 4G , S4C, and S4E). A critical issue would be how the inhibition of PFK1 and ENO1 activity by ULK1/2 can be reconciled to the sustained glycolysis observed in WT cells ( Figures 1A, 1B , and S1C-S1E). One possibility is that the contribution of phosphorylated HK1 and FBP1 in stimulating overall glycolysis may override the opposite effects caused by inhibition of PFK1 and ENO1 as the varied enzymatic activities after phosphorylation by ULK1/2 sum up to sustain glycolysis under nutritional stress. It is also formally possible that ULK1/2 can phosphorylate more as-yetunidentified substrates involved in glucose metabolism, which would await advent of a complete plethora of the targets of ULK1/2. Nevertheless, it is clear that inhibition of the enzymatic activities of PFK1 and ENO1 acts to maintain the level of G6P based on our metabolomic studies and thereby likely to divert relatively more glucose flux to PPP ( Figures 4J-4M, S4L , and S4P). Previous work showed that inhibition of PFK1 by O-GlcNAcylation during hypoxia promotes PPP activity and enhances cell survival (Yi et al., 2012) , emphasizing the importance of repression of PFK1 in maintaining PPP activity during stresses. Another concern is that the blunted ENO1 activity after ULK1/2-mediated phosphorylation may have an adverse effect on the processing of intermediates recovered from the non-oxidative branch of PPP. In fact, the intermediates from PPP in the form of GAP and F6P can also be converted back to G6P and replenish the oxidative branch of PPP (Riganti et al., 2012) , forming a closed cycle of PPP that excludes ENO1 activity under circumstances such as nutrient deprivation when large amount of NADPH is needed, such that a relatively higher PPP flux can be continuously maintained ( Figures 4M, S4L , and S4P). In support of the above notion is that suppression of pyruvate kinase M2, which is located downstream of ENO1 in the glycolytic pathway, diverts more glucose to PPP in response to oxidative stress (Anastasiou et al., 2011) .
It is commonly believed that gluconeogenesis occurs mostly in hepatic and renal cells (Scrutton and Utter, 1968) . Indeed, we found that FBP1 activity in MEFs is too low to be detected. However, the expression of certain gluconeogenic enzymes including PEP carboxykinase and FBP1 has been reported in a variety of other type of cells originated from tissues including prostate, stomach, lung, and small intestine (Yá nez et al., 2003) . For example, human breast cancer MCF7 cells express functional and significant amount of FBP1 (Dong et al., 2013) . Moreover, we detected both basal protein level and S63-phosphorylated FBP1 in HCT116 cells and cells expressing shRNA-targeting endogenous FBP1 showed increased glucose consumption and lactate production by approximately 37% (Figures 4A and  S4B) , which is consistent with the finding that genetic loss of FBP1 often causes sudden infant death characterized by hypoglycemia and lactic acidosis (Emery et al., 1988) . These results confirm the existence of meaningful FBP1 in some cancer lines to impact glucose metabolism. Meanwhile, the phosphorylation of FBP1 may not only affect the rate of the reaction of F-1,6-P back to F6P in glycolysis but also impinge on other functions of FBP1 such as its modulation of the nuclear hypoxia-inducible factor (HIF) (Li et al., 2014) , although it was shown that expression levels of FBP1 play a dominant role in this process. Of note, the activation or inhibition of FBP1 can only affect the absolute values of PPP flux, which is indirectly caused by the altered glucose consumption rate but cannot affect the ratio of PPP flux versus glycolytic flux.
Autophagy plays a critical role for cell survival in response to nutrient deprivation and various other stresses (Galluzzi et al., 2014; Rabinowitz and White, 2010; Xie and Klionsky, 2007) . Meanwhile, under many conditions such as amino acid and growth factor deprivation, the utilization of glucose in the environment could also be tightly regulated and vital for cell fate determination. Importantly, as glucose is transported by facilitated diffusion, which is a passive transport process, and our ''starvation medium'' contains a regular concentration of glucose, it is thus rational for the cells to intake glucose even in the absence of amino acid and serum. Indeed, we found that, although the rate of glucose consumption decreased in response to amino acid and serum starvation in WT cells, depletion of ULK1/2 led to a further significantly lower glucose consumption rate ( Figures 1A, 1B , and S1C-S1E). Consistently, knockout of FIP200, an essential gene for the kinase activity of endogenous ULK1/2 (Hara et al., 2008) , reduces glucose uptake and intracellular lactate production in mammary tumor cells (Wei et al., 2011) , pointing to a crucial role of ULK1/2 complexes in sustaining glycolytic flux. Moreover, we found that the function of ULK1/2 in the regulation of glucose metabolism does not rely on downstream autophagic events ( Figure 6 ). In addition, ATG7, another critical factor of the autophagy core machinery, has been reported to regulate p53-dependent cell cycle and cell death pathways independently of autophagy during metabolic stress (Lee et al., 2012) . These evidences suggest that multi-functionality could be a common feature for autophagicrelated genes.
Altogether, we have identified an adaptive mechanism for the reprogramming of glucose metabolism in response to amino acid and growth factor deprivation, in which ULK1/2 function by simultaneously altering the enzymatic activities of multiple glycolytic enzymes to sustain the production of energy and reducing forces and thus maintain the overall metabolic homeostasis besides their classical role in autophagy. An increasing body of evidence demonstrates that disrupted cellular glucose metabolic and redox balance tightly links with various pathological disorders (DeBerardinis and Thompson, 2012; Kawagishi and Finkel, 2014; Levine and Puzio-Kuter, 2010; Vander Heiden et al., 2009) . Elucidation of the functions of ULK1/2 in glucose catabolism may therefore provide new therapeutic strategies for prevention and treatment of human metabolic diseases.
EXPERIMENTAL PROCEDURES
For detailed protocols, see Supplemental Experimental Procedures.
Cell Culture, Transient Transfection, Lentivirus Infection, Immunoprecipitation, Western Blotting, and Animal Care HCT116, HEK293T, and MEFs were maintained in DMEM supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine, 100 IU penicillin, and 100 mg/ml streptomycin at 37 C in a humidified incubator containing 5% CO 2 . For amino acid and serum starvation medium, unless otherwise specified, Earle's Balanced Salts Solution (EBSS) (cat. 24010-043; GIBCO) was supplemented with 0.25% BSA, glucose, vitamins, and minerals at the same concentrations as in DMEM. Polyethylenimine at a final concentration of 10 mM was used to transfect HEK293T cells. Transfected cells were harvested at 24 hr after transfection. Lentiviruses for infection of HCT116 and MEFs were packaged in HEK293T cells using Lipofectamine 2000 transfection. Thirty hours after transfection, medium was collected and added to the target cells. Cell lysis, immunoprecipitation (IP), and western blotting were carried out as previously described (Lin et al., 2012) . All animal experiments were approved by the Institutional Animal Care and Use Committee at Xiamen University.
Statistical Analysis
For experiments with only two groups, Student's t test was used for statistical comparisons. ANOVA with Tukey's post-test (one-way ANOVA for comparisons between groups; two-way ANOVA for comparisons of magnitude of changes between different groups from different cell lines or treatments) was used to compare values among different experimental groups using the SPSS Statistics 17.0 program. p < 0.05 was considered as statistically significant (*) and p < 0.01 as highly significant (**). 
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